References
- C. Alving.(1992). Immunologic aspect of liposomes: preparation and processing of liposomal protein and phospholipid antigens Biochim. Biophys. Acta 1113:307–322.
- C. Artmann, J. Röding, M. Ghyczy, H. Pratzel.(1990). Liposomes from soya phospholipids as percutaneous drug carriers Arzneim.‐Forsch./Drug Res. 40:1365–1368.
- S. Benita, P. Poly, F. Puisieux, J. Delattre.(1984). Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency J. Pharm. Sci. 73:1751–1754.
- G. Betageri, C. Black, J. Szebeni, L. Wahl, J. Weinstein.(1993). Fc‐receptor‐mediated targeting of antibody‐bearing liposomes containing dideoxycytidine triphosphate to human monocyte/Macrophages J. Pharm. Pharmacol 45:48–53.
- G. Cevc, G. Blume.(1992). lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force Biochim. Biophys. Acta 1104:226–232.
- A. Downes, A. Matoltsy, T. Sweenty.(1967). Rate of turnover of the stratum corneum in hairless mice J. Invest. Dermatol. 49:400–407.
- K. Egbaria, N. Weiner.(1990). Liposomes as topical drug delivery system Adv. Drug Deliv. Rev. 5:287–300.
- K. Egbaria, C. Ramachandran, N. Weiner.(1990a). Topical delivery of cyclosporin: evaluations of various formulations using in‐vitro diffusion studies in hairless mouse skin Skin Pharmacol. 3:21–28.
- K. Egbaria, C. Ramachandran, D. Kittayanond, N. Weiner.(1990b). Topical delivery of liposomal IFN Antimicrob. Agents Chemother. 34:107–110.
- K. Egbaria, N. Weiner.(1991). Topical application of liposomal preparation Cosmet. Toilet. 106:79–93.
- M. Fresta, G. Puglisi, C. Di Giacomo, A. Russo.(1994). Liposomes as in‐vivo carriers for citicoline: effects on rat cerebral post‐ischaemic reperfusion J. Pharm. Pharmacol 46:974–981.
- M. Fresta, A. Spadaro, G. Cerniglia, I. Ropero, G. Puglisi, P. Furneri.(1995). Intracellular accumulation of ofloxacin‐loaded liposomes in human synovial fibroblasts Antimicrob. Agents Chemother. 39:1372–1375.
- N. Ho, M. Ganesan, N. Weiner, G. Flynn.(1985). Mechanism of topical delivery of liposomally entrapped drugs J. Control. Rel. 2:61–65.
- M. Jacobs, G. Martin, C. Marriott.(1987). A comparison of corticosteroid bioavailability from semisolid and liposome formulations J. Pharm. Pharmacol. 39:142P
- M. Jacobs, G. Martin, C. Marriott.(1988). Effects of phosphatidylcholine on the topical bioavailability of corticosteroids assessed by the human skin blanching assay J. Pharm. Pharmacol 40:829–833.
- A. Kato, Y. Ishibashi, Y. Miyake.(1987). Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride J. Pharm. Pharmacol 39:399–400.
- H. Korting, P. Blecher, M. Schäfer‐Korting, A. Wendel.(1991). Topical liposome drugs to come: what the patent literature tells us J. Am. Acad. Dermatol 25:1068–1071.
- H. Loth.(1991). Vehicular influence on transdermal drug penetration Int. J. Pharm. 68:1–10.
- M. Mezei, V. Gulasekharam.(1980). Liposome—a selective drug delivery system for the topical route of administration Life Sci 26:1473–1477.
- M. Mezei, V. Gulasekharam.(1982). Liposome—A selective drug delivery system for the topical route of administration: gel dosage form J. Pharm. Pharmacol 34:473–474.
- G. Puglisi, M. Fresta, G. Mazzone, P. Furneri, G. Tempera.(1995). Formulation parameters of fluoroquinolone‐loaded liposomes and in vitro antimicrobial activity Int. J. Pharm. 118:65–76.
- N. Weiner, F. Martin, M. Riaz.(1989). Liposomes as drug delivery system (review) Drug Dev. Ind. Pharm. 15:1523–1535.
- W. Wohlrab.(1984). The influence of urea on the penetration kinetics of topically applied corticosteroids Acta Derm. Venereol. 64:233–238.
- G. Cevc.(1992). Liposome Dermatics82–90.
- E. Cooper.(1985). Percutaneous Absorption525–531.
- G. Gregoriadis.(1988). Liposomes as drug carrier